BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 35804881)

  • 1. Mesothelioma Mouse Models with Mixed Genomic States of Chromosome and Microsatellite Instability.
    Song Y; Baxter SS; Dai L; Sanders C; Burkett S; Baugher RN; Mellott SD; Young TB; Lawhorn HE; Difilippantonio S; Karim B; Kadariya Y; Pinto LA; Testa JR; Shoemaker RH
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.
    Menges CW; Kadariya Y; Altomare D; Talarchek J; Neumann-Domer E; Wu Y; Xiao GH; Shapiro IM; Kolev VN; Pachter JA; Klein-Szanto AJ; Testa JR
    Cancer Res; 2014 Feb; 74(4):1261-1271. PubMed ID: 24371224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar tumor suppressor gene alteration profiles in asbestos-induced murine and human mesothelioma.
    Lecomte C; Andujar P; Renier A; Kheuang L; Abramowski V; Mellottee L; Fleury-Feith J; Zucman-Rossi J; Giovannini M; Jaurand MC
    Cell Cycle; 2005 Dec; 4(12):1862-9. PubMed ID: 16319530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma.
    Sneddon S; Patch AM; Dick IM; Kazakoff S; Pearson JV; Waddell N; Allcock RJN; Holt RA; Robinson BWS; Creaney J
    BMC Cancer; 2017 Jun; 17(1):396. PubMed ID: 28577549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mouse model recapitulating molecular features of human mesothelioma.
    Altomare DA; Vaslet CA; Skele KL; De Rienzo A; Devarajan K; Jhanwar SC; McClatchey AI; Kane AB; Testa JR
    Cancer Res; 2005 Sep; 65(18):8090-5. PubMed ID: 16166281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syntenic relationships between genomic profiles of fiber-induced murine and human malignant mesothelioma.
    Jean D; Thomas E; Manié E; Renier A; de Reynies A; Lecomte C; Andujar P; Fleury-Feith J; Galateau-Sallé F; Giovannini M; Zucman-Rossi J; Stern MH; Jaurand MC
    Am J Pathol; 2011 Feb; 178(2):881-94. PubMed ID: 21281820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models of malignant mesothelioma.
    Kane AB
    Inhal Toxicol; 2006 Nov; 18(12):1001-4. PubMed ID: 16920675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis.
    Mezei G; Chang ET; Mowat FS; Moolgavkar SH
    Scand J Work Environ Health; 2021 Jan; 47(1):85-86. PubMed ID: 32626907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of
    Kukuyan AM; Sementino E; Kadariya Y; Menges CW; Cheung M; Tan Y; Cai KQ; Slifker MJ; Peri S; Klein-Szanto AJ; Rauscher FJ; Testa JR
    Cancer Res; 2019 Aug; 79(16):4113-4123. PubMed ID: 31151962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic and molecular genetic changes in malignant mesothelioma.
    Musti M; Kettunen E; Dragonieri S; Lindholm P; Cavone D; Serio G; Knuutila S
    Cancer Genet Cytogenet; 2006 Oct; 170(1):9-15. PubMed ID: 16965949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bortezomib inhibits nuclear factor-kappaB dependent survival and has potent in vivo activity in mesothelioma.
    Sartore-Bianchi A; Gasparri F; Galvani A; Nici L; Darnowski JW; Barbone D; Fennell DA; Gaudino G; Porta C; Mutti L
    Clin Cancer Res; 2007 Oct; 13(19):5942-51. PubMed ID: 17908991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron overload as a major targetable pathogenesis of asbestos-induced mesothelial carcinogenesis.
    Toyokuni S
    Redox Rep; 2014 Jan; 19(1):1-7. PubMed ID: 24257681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma.
    Napolitano A; Pellegrini L; Dey A; Larson D; Tanji M; Flores EG; Kendrick B; Lapid D; Powers A; Kanodia S; Pastorino S; Pass HI; Dixit V; Yang H; Carbone M
    Oncogene; 2016 Apr; 35(15):1996-2002. PubMed ID: 26119930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Authors' response: Mezei et al's "Comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis".
    Marinaccio A; Consonni D; Mensi C; Mirabelli D; Migliore E; Magnani C; Di Marzio D; Gennaro V; Mazzoleni G; Girardi P; Negro C; Romanelli A; Chellini E; Grappasonni I; Madeo G; Romeo E; Ascoli V; Carrozza F; Angelillo IF; Cavone D; Tumino R; Melis M; Curti S; Brandi G; Mattioli S; Iavicoli S;
    Scand J Work Environ Health; 2021 Jan; 47(1):87-89. PubMed ID: 33388783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation-Related IL1β/IL1R Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma.
    Kadariya Y; Menges CW; Talarchek J; Cai KQ; Klein-Szanto AJ; Pietrofesa RA; Christofidou-Solomidou M; Cheung M; Mossman BT; Shukla A; Testa JR
    Cancer Prev Res (Phila); 2016 May; 9(5):406-414. PubMed ID: 26935421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide analysis of abdominal and pleural malignant mesothelioma with DNA arrays reveals both common and distinct regions of copy number alteration.
    Borczuk AC; Pei J; Taub RN; Levy B; Nahum O; Chen J; Chen K; Testa JR
    Cancer Biol Ther; 2016; 17(3):328-35. PubMed ID: 26853494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomas.
    Sementino E; Menges CW; Kadariya Y; Peri S; Xu J; Liu Z; Wilkes RG; Cai KQ; Rauscher FJ; Klein-Szanto AJ; Testa JR
    J Cell Physiol; 2018 Nov; 233(11):8952-8961. PubMed ID: 29904909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma.
    Xu J; Kadariya Y; Cheung M; Pei J; Talarchek J; Sementino E; Tan Y; Menges CW; Cai KQ; Litwin S; Peng H; Karar J; Rauscher FJ; Testa JR
    Cancer Res; 2014 Aug; 74(16):4388-97. PubMed ID: 24928783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma.
    Alakus H; Yost SE; Woo B; French R; Lin GY; Jepsen K; Frazer KA; Lowy AM; Harismendy O
    J Transl Med; 2015 Apr; 13():122. PubMed ID: 25889843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma.
    Murthy SS; Testa JR
    J Cell Physiol; 1999 Aug; 180(2):150-7. PubMed ID: 10395284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.